Related references
Note: Only part of the references are listed.The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice
Xue Feng et al.
HEPATOLOGY (2020)
A novel EWSR1-VGLL1 gene fusion in a soft tissue malignant myoepithelial tumor
Masato Komatsu et al.
GENES CHROMOSOMES & CANCER (2020)
Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm
Adam J. Kundishora et al.
CLINICAL GENETICS (2020)
Deep sequencing of myxoinflammatory fibroblastic sarcoma
Elsa Arbajian et al.
GENES CHROMOSOMES & CANCER (2020)
The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1
Seiichiro Mori et al.
JOURNAL OF VIROLOGY (2020)
VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma
Lihua Zhang et al.
SCIENTIFIC REPORTS (2020)
Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway
Naoto Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Transcriptional cofactor Vgll2 is required for functional adaptations of skeletal muscle induced by chronic overload
Masahiko Honda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
VGLL4 plays a critical role in heart valve development and homeostasis
Wei Yu et al.
PLOS GENETICS (2019)
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
Nicolas Figeac et al.
JOURNAL OF CELL SCIENCE (2019)
The Hippo Signaling Pathway in Development and Disease
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2019)
Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor
Yangyang Yao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer
Li-Hua Zhang et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer
Hongming Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
Ivan M. Moya et al.
SCIENCE (2019)
Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion
Ailing Wu et al.
EMBO JOURNAL (2019)
PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer
Bo-Kyung Kim et al.
CANCERS (2019)
The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity
Allison C. Billi et al.
JCI INSIGHT (2019)
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al.
TRENDS IN CANCER (2019)
Targeting Transcriptional Enhanced Associate Domains (TEADs)
Floriane Gibault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Transcriptomic definition of molecular subgroups of small round cell sarcomas
Sarah Watson et al.
JOURNAL OF PATHOLOGY (2018)
miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4
Xiaowu Liu et al.
ONCOLOGY REPORTS (2018)
Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma
Bo Shu et al.
SCIENTIFIC REPORTS (2018)
Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2/M phase arrest and apoptosis promotion
Wenjie Xie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4
Jinhua Hu et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity
Yongji Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Regulation of the Hippo Pathway Transcription Factor TEAD
Kimberly C. Lin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
Shi Jiao et al.
NATURE COMMUNICATIONS (2017)
Vestigial-like 3 is a novel Ets1 interacting partner and regulates trigeminal nerve formation and cranial neural crest migration
Emilie Simon et al.
BIOLOGY OPEN (2017)
Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
Jian Han et al.
SCIENTIFIC REPORTS (2017)
VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
Yinglong Zhang et al.
SCIENTIFIC REPORTS (2017)
Vestigial-like 2 contributes to normal muscle fiber type distribution in mice
Masahiko Honda et al.
SCIENTIFIC REPORTS (2017)
The ETS family of oncogenic transcription factors in solid tumours
Gina M. Sizemore et al.
NATURE REVIEWS CANCER (2017)
A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases
Rita Alaggio et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells
Hong-Mei Zhang et al.
CANCER RESEARCH (2016)
From vestigial to vestigial-like: the Drosophila gene that has taken wing
Emilie Simon et al.
DEVELOPMENT GENES AND EVOLUTION (2016)
Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth
Zhiqiang Lin et al.
DEVELOPMENTAL CELL (2016)
The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
Yuhang Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis
Shuying Shen et al.
CELL RESEARCH (2015)
VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer
Hui Li et al.
MEDICAL ONCOLOGY (2015)
Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome
Ana Tufegdzic Vidakovic et al.
CELL REPORTS (2015)
Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma
Wei Jiang et al.
TUMOR BIOLOGY (2015)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
Maria Angeles Castilla et al.
ENDOCRINE-RELATED CANCER (2014)
The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review
Cyril Fisher
HISTOPATHOLOGY (2014)
Emerging roles of TEAD transcription factors and its coactivators in cancers
Ajaybabu V. Pobbati et al.
CANCER BIOLOGY & THERAPY (2013)
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer
Karen Gambaro et al.
MOLECULAR ONCOLOGY (2013)
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Evan R. Barry et al.
NATURE (2013)
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
Karen M. Mann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Ajaybabu V. Pobbati et al.
STRUCTURE (2012)
A novel inhibitor of apoptosis protein (IAP)-interacting protein, Vestigial-like (Vgl)-4, counteracts apoptosis-inhibitory function of IAPs by nuclear sequestration
Hyung-Seung Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
Allen C. T. Teng et al.
FASEB JOURNAL (2010)
YAP1 and VGLL3, Encoding Two Cofactors of TEAD Transcription Factors, Are Amplified and Overexpressed in a Subset of Soft Tissue Sarcomas
Zofia Helias-Rodzewicz et al.
GENES CHROMOSOMES & CANCER (2010)
Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates
Corinne Faucheux et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
VITO-2, a new SID domain protein, is expressed in the myogenic lineage during early mouse embryonic development
Michal Mielcarek et al.
GENE EXPRESSION PATTERNS (2009)
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions
Karolin H. Hallor et al.
JOURNAL OF PATHOLOGY (2009)
Characterization of the 3p12.3-pcen Region Associated With Tumor Suppression in a Novel Ovarian Cancer Cell Line Model Genetically Modified by Chromosome 3 Fragment Transfer
Neal A. L. Cody et al.
MOLECULAR CARCINOGENESIS (2009)
Yes-associated protein (YAP) functions as a tumor suppressor in breast
M. Yuan et al.
CELL DEATH AND DIFFERENTIATION (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Sveinsson's chorioretinal atrophy-associated missense mutation in mouse Tead1 affects its interaction with the co-factors YAP and TAZ
Michinori Kitagawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p
N. A. L. Cody et al.
ONCOGENE (2007)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates α1-adrenergic activation of gene expression in cardiac myocytes
HH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation
T Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
